| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |